Nektar Therapeutics, Rubrik, and SentinelOne Earnings Preview
Las Vegas, NV / CRWE PRESS RELEASE / March 8, 2026 - Among the companies expected to release financial results on Thursday, March 12, are
Nektar Therapeutics (Nasdaq: NKTR), a biotechnology company focused on developing therapies for autoimmune disorders and cancer, will announce its financial figures for the fourth quarter and the year ended 2025 after the close of U.S. markets. Analysts expect a loss of $3.49 per share on revenue of $10.41 million. $NKTR closed Friday at $70.70, down $1.75, or 2.42%.
Rubrik, Inc. (NYSE: RBRK), a cloud data management and cybersecurity company specializing in data protection, backup, and ransomware recovery solutions, will release its fourth-quarter and fiscal year 2026 results after the closing bell. Wall Street expects a loss of $0.11 per share on revenue of $342.37 million. $RBRK ended Friday at $57.17, up $1.29, or 2.31%.
SentinelOne, Inc. (NYSE: S), a cybersecurity firm known for its AI-powered endpoint security platform, will deliver its fourth-quarter and fiscal year 2026 financial results following the market close. The consensus loss estimate stands at $0.18 per share, with revenue projected to reach $271.16 million. On Friday, $S closed at $14.19, up $0.22, or 1.57%.
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)
© 2026 CRWE PRESS RELEASE. All Rights Reserved.
